New hope for pemphigus patients: B007 aims for remission with less medication
NCT ID NCT06454357
First seen May 06, 2026 · Last updated May 08, 2026 · Updated 1 time
Summary
This study tests a new drug, B007, in 132 people with pemphigus, a serious blistering skin disease. The goal is to see if B007 can help patients achieve complete remission while needing only minimal ongoing treatment. The trial is for newly diagnosed or relapsed patients and will also monitor side effects and relapse rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEMPHIGUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chengdu Second People's Hospital
RECRUITINGChengdu, China
Contact
-
Dermatology Hospital of Southern Medical University
RECRUITINGGuangzhou, China
Contact
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, China
Contact
-
Henan Provincial People's Hospital
RECRUITINGZhengzhou, China
Contact
-
Peking University First Hospital
RECRUITINGBeijing, China
Contact
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
RECRUITINGShanghai, China
Contact
-
Shandong First Medical University-Affiliated Skin Hospital
RECRUITINGJinan, China
Contact
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, China
Contact
-
The First Affiliated Hospital of Fujian Medical University
RECRUITINGFuzhou, China
Contact
-
The Second Xiangya Hospital of Central South University
RECRUITINGChangsha, China
Contact
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, China
Contact
-
West China Hospital, Sichuan University
RECRUITINGChengdu, China
Contact
Conditions
Explore the condition pages connected to this study.